MarketCapExport financials
Westlake Chemical Corporation (WLK)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Westlake Chemical Corporation Balance Sheet 2025-2008 | WLK
Brief overview of Westlake Chemical Corporation's balance sheet structure
The balance sheet is assessed across five available annual reports spanning 2021 to 2025.
The asset base gained +8.1%, from $18.5 billion to $20 billion; average annual growth of 2% remained moderate.
The growth rates were balanced: assets changed +8.1%, while liabilities changed +7.4%.
Equity finances 44% of the balance sheet, compared with 43.1% at the start. The cushion remains adequate.
Net debt equals roughly 0.28x of equity. This is a moderate load and leaves room for maneuver.
The cash share moved from 10.3% to 13.6%. A higher figure generally provides more room in an adverse scenario.
Retained earnings are $8.7 billion versus $7.8 billion initially. The direction shows how results contributed to equity.
Conclusion
Westlake Chemical Corporation retains a reasonably healthy balance sheet structure, which still needs support from earnings and cash flow.
Annual Balance Sheet Westlake Chemical Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
2.5 B | 1.76 B | 1.43 B | 2.77 B | 3.11 B | 2.32 B | 3.07 B | 1.92 B | 2.31 B | 3.37 B | 622 M | -117 M | 542 M | 98.6 M | -61.3 M | 134 M | - | - |
Long Term Debt |
5.09 B | 4.56 B | 4.61 B | 4.88 B | 4.91 B | 3.57 B | 3.44 B | 2.67 B | 3.13 B | 3.68 B | 764 M | 764 M | 764 M | 764 M | 765 M | 764 M | - | - |
Long Term Debt Current |
138 M | 128 M | 124 M | 116 M | 106 M | 89 M | 93 M | - | 710 M | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | 5.62 B | 4.34 B | 4.74 B | 5.82 B | 1.49 B | 1.47 B | 1.24 B | 1.14 B | 1.15 B | - | - | - |
Total Current Liabilities |
2.77 B | 2.22 B | 2.79 B | 2.3 B | 2.34 B | 1.36 B | 1.24 B | 1.18 B | 1.97 B | 1.18 B | 523 M | 537 M | 405 M | 399 M | 365 M | 324 M | - | - |
Total Liabilities |
10.7 B | 9.71 B | 10.3 B | 10.1 B | 9.93 B | 7.26 B | 6.86 B | 5.53 B | 6.71 B | 7 B | 2.01 B | 2.01 B | 1.64 B | 1.54 B | 1.51 B | 1.45 B | - | - |
Retained Earnings |
8.7 B | 10.5 B | 10.1 B | 9.88 B | 7.81 B | 5.94 B | 5.76 B | 5.48 B | 4.61 B | 3.41 B | 3.11 B | 2.56 B | 1.95 B | 1.4 B | 1.3 B | 1.06 B | - | - |
Total Assets |
20 B | 20.8 B | 21 B | 20.6 B | 18.5 B | 13.8 B | 13.3 B | 11.6 B | 12.1 B | 10.9 B | 5.58 B | 5.21 B | 4.06 B | 3.41 B | 3.27 B | 2.95 B | - | - |
Cash and Cash Equivalents |
2.72 B | 2.92 B | 3.3 B | 2.23 B | 1.91 B | 1.34 B | 728 M | 753 M | 1.53 B | 459 M | 663 M | 881 M | 461 M | 790 M | 826 M | 630 M | 246 M | 90.2 M |
Book Value |
9.3 B | 11 B | 10.8 B | 10.5 B | 8.53 B | 6.58 B | 6.4 B | 6.08 B | 5.37 B | 3.89 B | 3.56 B | 3.2 B | 2.42 B | 1.87 B | 1.76 B | 1.51 B | - | - |
Total Shareholders Equity |
8.79 B | 10.5 B | 10.2 B | 9.93 B | 7.96 B | 6.58 B | 5.86 B | 5.59 B | 4.87 B | 3.52 B | 3.27 B | 2.91 B | 2.42 B | 1.87 B | 1.76 B | 1.51 B | 1.28 B | 1.24 B |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Balance Sheet Westlake Chemical Corporation
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
5.07 B | 5.07 B | 3.91 B | 4.65 B | 4.59 B | 4.62 B | 4.58 B | 4.59 B | 4.57 B | 4.89 B | 4.89 B | 4.88 B | 4.81 B | - | 4.9 B | 4.91 B | 4.93 B | 3.56 B | 3.55 B | 3.57 B | 3.57 B | 3.57 B | 3.57 B | 3.44 B | 3.44 B | 3.44 B | 3.44 B | 2.67 B | 2.67 B | 2.67 B | 2.67 B | 3.13 B | 3.13 B | 3.13 B | 3.13 B | 3.68 B | 3.68 B | 3.68 B | 3.68 B | 758 M | 764 M | 764 M | 764 M | 764 M | 764 M | 764 M | 764 M | 764 M | 764 M | 764 M | 764 M | 764 M | 764 M | 764 M | 764 M | 765 M | 765 M | 765 M | 765 M |
Total Liabilities |
10.2 B | 10.7 B | 9.88 B | 10 B | 9.79 B | 9.92 B | 9.99 B | 10.1 B | 10.1 B | 9.9 B | 9.98 B | 10.1 B | 10.2 B | - | 10.5 B | 9.93 B | 9.24 B | 7.38 B | 7.22 B | 7.26 B | 7.26 B | 7.26 B | 7.26 B | 6.86 B | 6.86 B | 6.86 B | 6.86 B | 5.53 B | 5.53 B | 5.53 B | 5.53 B | 6.71 B | 6.71 B | 6.71 B | 6.71 B | 7 B | 7 B | 7 B | 7 B | 2.01 B | 2.01 B | 2.01 B | 2.01 B | 2.01 B | 2.01 B | 2.01 B | 2.01 B | 1.64 B | 1.64 B | 1.64 B | 1.64 B | 1.54 B | 1.54 B | 1.54 B | 1.54 B | 1.51 B | 1.51 B | 1.51 B | 1.51 B |
Retained Earnings |
8.66 B | 8.46 B | 9.31 B | 10.2 B | 10.4 B | 10.5 B | 10.5 B | 10.3 B | 10.7 B | 10.5 B | 10.2 B | 9.88 B | 9.7 B | - | 8.52 B | 7.81 B | 7.2 B | 6.63 B | 6.14 B | 5.94 B | 5.94 B | 5.94 B | 5.94 B | 5.76 B | 5.76 B | 5.76 B | 5.76 B | 5.48 B | 5.48 B | 5.48 B | 5.48 B | 4.61 B | 4.61 B | 4.61 B | 4.61 B | 3.41 B | 3.41 B | 3.41 B | 3.41 B | 3.11 B | 3.11 B | 3.11 B | 3.11 B | 2.56 B | 2.56 B | 2.56 B | 2.56 B | 1.95 B | 1.95 B | 1.95 B | 1.95 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.3 B | 1.3 B | 1.3 B | 1.3 B |
Total Assets |
19.4 B | 19.7 B | 19.8 B | 20.8 B | 20.7 B | 21.1 B | 21.1 B | 21 B | 21.4 B | 21 B | 20.8 B | 20.6 B | 20.4 B | - | 19.7 B | 18.5 B | 17.1 B | 14.7 B | 14 B | 13.8 B | 13.8 B | 13.8 B | 13.8 B | 13.3 B | 13.3 B | 13.3 B | 13.3 B | 11.6 B | 11.6 B | 11.6 B | 11.6 B | 12.1 B | 12.1 B | 12.1 B | 12.1 B | 10.9 B | 10.9 B | 10.9 B | 10.9 B | 5.57 B | 5.57 B | 5.57 B | 5.57 B | 5.21 B | 5.21 B | 5.21 B | 5.21 B | 4.06 B | 4.06 B | 4.06 B | 4.06 B | 3.41 B | 3.41 B | 3.41 B | 3.41 B | 3.27 B | 3.27 B | 3.27 B | 3.27 B |
Cash and Cash Equivalents |
1.64 B | 2.27 B | 1.93 B | 2.08 B | 2.3 B | 2.93 B | 3.06 B | 3.12 B | 3.07 B | 2.69 B | 2.43 B | 2.23 B | 1.81 B | 1.34 B | 1.08 B | 1.91 B | 3.61 B | 1.84 B | 1.39 B | 1.31 B | 1.31 B | 1.31 B | 1.31 B | 728 M | 728 M | 728 M | 728 M | 753 M | 753 M | 753 M | 753 M | 1.53 B | 1.53 B | 1.53 B | 1.53 B | 459 M | 459 M | 459 M | 459 M | 663 M | 663 M | 663 M | 663 M | 881 M | 881 M | 881 M | 881 M | 461 M | 461 M | 461 M | 461 M | 790 M | 790 M | 790 M | 790 M | 826 M | 826 M | 826 M | 826 M |
Book Value |
9.21 B | 9.05 B | 9.94 B | 10.8 B | 10.9 B | 11.2 B | 11.1 B | 10.9 B | 11.3 B | 11.1 B | 10.8 B | 10.5 B | 10.2 B | - | 9.25 B | 8.53 B | 7.87 B | 7.34 B | 6.82 B | 6.58 B | 6.58 B | 6.58 B | 6.58 B | 6.4 B | 6.4 B | 6.4 B | 6.4 B | 6.08 B | 6.08 B | 6.08 B | 6.08 B | 5.37 B | 5.37 B | 5.37 B | 5.37 B | 3.89 B | 3.89 B | 3.89 B | 3.89 B | 3.56 B | 3.56 B | 3.56 B | 3.56 B | 3.2 B | 3.2 B | 3.2 B | 3.2 B | 2.42 B | 2.42 B | 2.42 B | 2.42 B | 1.87 B | 1.87 B | 1.87 B | 1.87 B | 1.76 B | 1.76 B | 1.76 B | 1.76 B |
Total Shareholders Equity |
8.7 B | 8.55 B | 9.43 B | 10.3 B | 10.4 B | 11.2 B | 11.1 B | 10.9 B | 11.3 B | 11.1 B | 10.8 B | 9.93 B | 10.2 B | 9.97 B | 9.25 B | 7.96 B | 7.87 B | 7.34 B | 6.82 B | 6.04 B | 6.04 B | 6.04 B | 6.04 B | 5.86 B | 5.86 B | 5.86 B | 5.86 B | 5.59 B | 5.59 B | 5.59 B | 5.59 B | 4.87 B | 4.87 B | 4.87 B | 4.87 B | 3.52 B | 3.52 B | 3.52 B | 3.52 B | 3.27 B | 3.27 B | 3.27 B | 3.27 B | 2.91 B | 2.91 B | 2.91 B | 2.91 B | 2.42 B | 2.42 B | 2.42 B | 2.42 B | 1.87 B | 1.87 B | 1.87 B | 1.87 B | 1.76 B | 1.76 B | 1.76 B | 1.76 B |
Quarterly performance
Select metrics to display
All numbers in USD currency
Balance Sheet is a fundamental financial report of Westlake Chemical Corporation, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
USA
Canada
Britain
Niderland
Luxembourg
